Antidote Therapeutics, Inc.

BioTech/Drugs - Gaithersburg, MD, US

Antidote Therapeutics, Inc. Employees
Michael Molle

Head of Program Management

Contact Michael Molle

Anthony Coniglio

Head, Business and Commercial Development

Contact Anthony Coniglio

Contact All Antidote Therapeutics, Inc. Employees
Antidote Therapeutics, Inc. Senior Management
Contact All Antidote Therapeutics, Inc. Employees
Antidote Therapeutics, Inc. Details

Antidote Therapeutics, Inc. is a biopharmaceutical company developing drugs for treating diseases caused or worsened by nicotine. Antidote's portfolio offers unique first-in-class approach to block nicotine's harmful effects on the brain and other organs: • Fully human, anti-nicotine monoclonal antibody (ATI-1013) • Nicotine-degrading enzyme (ATI-3009)Unlike current FDA-approved smoking cessation treatments, Antidote's candidates do not contain nicotine or interact with nicotine-receptors in the brain or body. Instead, our drugs are designed to trap or eliminate nicotine in the blood, having the dual benefit of 1) neutralizing nicotine's direct, harmful effects on organs throughout the body and 2) preventing nicotine from reaching the brain, reducing the addictiveness of nicotine from cigarettes, e-cigarettes, and smokeless tobacco.Antidote's innovative development strategy (focused on treating existing disease to improve medical outcomes rather than preventing future smoking-related illnesses that may occur decades later) is significantly different from how other drugs that target nicotine's actions have been developed as aids to smoking cessation. The first indications for Antidote's anti-nicotine drugs are the treatment of orphan vascular diseases in smokers where nicotine plays an important role in causing disease progression, such as Buerger's Disease and Critical Limb Ischemia. Our products, which neutralize nicotine's direct cardiovascular effects, may also help patients quit or substantially reduce smoking. This is expected to lead to better overall treatment outcomes across all vascular disease patients. In the future, we plan to expand the uses of our products to other smoking-related illnesses where blocking nicotine's effects will have near-term medical benefit as well as a general aid to smoking cessation.

Antidote Therapeutics, Inc. logo, Antidote Therapeutics, Inc. contact details
Website: antidotetx.com
Employees: 5 - 9
HQ: N/A
Location: Gaithersburg, MD, US
Revenue: Not Available
Biotechnology Rare diseases Nicotine addiction Biopharmaceuticals Drug Development Vascular Disease Life Sciences Healthcare Public Health
Antidote Therapeutics, Inc. Technologies
Email Providers

Outlook

Load Balancers

Apache

CMS

WordPress.org

Other

Mobile Friendly

Analytics and Tracking

Google Analytics

View All Technologies Used At Antidote Therapeutics, Inc.

Contacting Antidote Therapeutics, Inc.: Connect with Executives and Employees

Get in Touch with Antidote Therapeutics, Inc. Executives and Employees

Connecting with Antidote Therapeutics, Inc.'s Executives and Workforce

Accessing Contact Information for Antidote Therapeutics, Inc. Executives

Connecting with Antidote Therapeutics, Inc.: Reach Out to Their Team

Discover How to Contact Antidote Therapeutics, Inc. Executives and Staff

Looking to connect with Antidote Therapeutics, Inc. executives or employees?

Seeking to Get in Touch with Antidote Therapeutics, Inc. Executives or Staff?

Want to Reach Out to Antidote Therapeutics, Inc. Executives or Team Members?

In Search of Contact Details for Antidote Therapeutics, Inc. Professionals?

Connecting with Antidote Therapeutics, Inc.: Contacting Executives and Staff

Browse companies
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z